Oxidative stress and nephrolithiasis: a comparative pilot study evaluating the effect of pomegranate extract on stone risk factors and elevated oxidative stress levels of recurrent stone formers and controls

Urolithiasis

Volumn 42, Issue 5, 2014, Pages 401-408

  Tracy, Chad R ^a   Henning, Jonathan R ^a   Newton, Mark R ^a   Aviram, Michael ^b   Bridget Zimmerman, M ^c  

^a UNIVERSITY OF IOWA   (United States)

^b RAMBAM MEDICAL CENTER   (Israel)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

Antioxidants; Dietary management; Medical management; Nephrolithiasis; Oxidative stress; Renal disease

Indexed keywords

ARYLESTERASE; C REACTIVE PROTEIN; CALCIUM OXALATE; POMEGRANATE EXTRACT; THIOBARBITURIC ACID REACTIVE SUBSTANCE; PLANT EXTRACT;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; LIPID PEROXIDATION; MALE; NEPHROLITHIASIS; OXIDATIVE STRESS; PILOT STUDY; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; STONE FORMATION; ADOLESCENT; AGED; LYTHRACEAE; METABOLISM; MIDDLE AGED; PHYTOTHERAPY; PROSPECTIVE STUDY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; NEPHROLITHIASIS; OXIDATIVE STRESS; PHYTOTHERAPY; PILOT PROJECTS; PLANT EXTRACTS; PROSPECTIVE STUDIES; PUNICACEAE; RECURRENCE; RISK FACTORS; YOUNG ADULT;

EID: 84927558870     PISSN: 21947228     EISSN: 21947236     Source Type: Journal    
DOI: 10.1007/s00240-014-0686-8     Document Type: Article

References (34)

1. Scales CD Jr, Smith AC, Hanley JM et al (2012) Urologic diseases in America P. Prevalence of kidney stones in the United States. Eur Urol 62:160
2. Lotan Y, Buendia Jimenez I, Lenoir-Wijnkoop I et al (2012) Primary prevention of nephrolithiasis is cost-effective for a national healthcare system. BJU Int 110:E1060
3. Tracy CR, Pearle MS (2009) Update on the medical management of stone disease. Curr Opin Urol 19:200
4. Khan SR (2013) Reactive oxygen species as the molecular modulators of calcium oxalate kidney stone formation: evidence from clinical and experimental investigations. J Urol 189:803
5. Holoch PA, Tracy CR (2011) Antioxidants and self-reported history of kidney stones: the National Health and Nutrition Examination Survey. J Endourol 25:1903
6. Boonla C, Wunsuwan R, Tungsanga K et al (2007) Urinary 8-hydroxydeoxyguanosine is elevated in patients with nephrolithiasis. Urol Res 35:185
7. Gaspar S, Niculite C, Cucu D et al (2010) Effect of calcium oxalate on renal cells as revealed by real-time measurement of extracellular oxidative burst. Biosens Bioelectron 25:1729
8. Tugcu V, Kemahli E, Ozbek E et al (2008) Protective effect of a potent antioxidant, pomegranate juice, in the kidney of rats with nephrolithiasis induced by ethylene glycol. J Endourol 22:2723
9. Ilbey YO, Ozbek E, Simsek A et al (2009) Effects of pomegranate juice on hyperoxaluria-induced oxidative stress in the rat kidneys. Ren Fail 31:522
10. Taylor EN, Fung TT, Curhan GC (2009) DASH-style diet associates with reduced risk for kidney stones. J Am Soc Nephrol 20:2253
11. Gil MI, Tomas-Barberan FA, Hess-Pierce B et al (2000) Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. J Agric Food Chem 10:4581
12. Ilbey YO, Ozbek E, Simsek A et al (2009) Effects of pomegranate juice on hyperoxaluria-induced oxidative stress in the rat kidneys. Ren Fail 31:522
13. Rathoda NR, Biswas D, Chitme HR et al (2012) Anti-urolithiatic effects of Punica granatum in male rats. J Ethnopharmacol 140:234
14. El-Saadani M, Esterbauer H, el-Sayed M et al (1989) A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J Lipid Res 30:627–630
15. Frei B, Stocker R, Ames BN (1988) Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci USA 85:9748
16. Buege JA, Aust SD (1978) Microsomal lipid peroxidation. Meth Enzymol 52:302
17. Getz GS, Reardon CA (2004) Paraoxonase, a cardioprotective enzyme: continuing issues. Current Opin Lipidol 15:261
18. Ruiz J, Blanche H, James RW et al (1995) Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes. Lancet 346:869
19. Odawara M, Tachi Y, Yamashita K (1997) Paraoxonase polymorphism (Gln192-Arg) is associated with coronary heart disease in Japanese noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 82:2257
20. Serrato M, Marian AJ (1995) A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease. J Clin Invest 96:3005
21. Gaidukov L, Tawfik DS (2007) The development of human sera tests for HDL-bound serum PON1 and its lipolactonase activity. J Lipid Res 48:1637
22. Obligado SH, Goldfarb DS (2008) The association of nephrolithiasis with hypertension and obesity: a review. Am J Hypertens 21:257
23. Lieske JC, de la Vega LS, Gettman MT et al (2006) Diabetes mellitus and the risk of urinary tract stones: a population-based case-control study. Am J Kidney Dis 48:897
24. Jeong IG, Kang T, Bang JK et al (2011) Association between metabolic syndrome and the presence of kidney stones in a screened population. Am J Kidney Dis 58:383
25. Saucier NA, Sinha MK, Liang KV et al (2010) Risk factors for CKD in persons with kidney stones: a case-control study in Olmsted County Minnesota. Am J Kidney Dis 55:61
26. Khan SR (2012) Is oxidative stress, a link between nephrolithiasis and obesity, hypertension, diabetes, chronic kidney disease, metabolic syndrome? Urol Res 40:95
27. Baggio B, Gambaro G, Ossi E et al (1983) Increased urinary excretion of renal enzymes in idiopathic calcium oxalate nephrolithiasis. J Urol 129:1161
28. Escobar C, Byer KJ, Khan SR (2007) Naturally produced crystals obtained from kidney stones are less injurious to renal tubular epithelial cells than synthetic crystals. BJU Int 100:891
29. Khan SR (2004) Crystal-induced inflammation of the kidneys: results from human studies, animal models, and tissue culture studies. Clin Exp Nephrol 8:75
30. Siener R, Petzold J, Bitterlich N et al (2013) Determinants of urolithiasis in patients with intestinal fat malabsorption. Urology 81:17
31. Thamilselvan S, Hackett RL, Khan SR (1997) Lipid peroxidation in ethylene glycol induced hyperoxaluria and calcium oxalate nephrolithiasis. J Urol 157:1059
32. Tugcu V, Ozbek E, Kemahli E et al (2007) Rapid communication: protective effect of a nuclear factor kappaB inhibitor, pyrolidium dithiocarbamate, in the kidney of rats with nephrolithiasis induced by ethylene glycol. J Endourol 21:1097
33. Aviram M, Rosenblat M, Gaitini D et al (2004) Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduced common carotid intima-media thickness, blood pressure and LDL oxidation. Clin Nutr 23:423
34. Eisner BH, Eisenberg ML, Stoller ML (2009) Impact of urine sodium on urine risk factors for calcium oxalate nephrolithiasis. J Urol 182:2330